NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $710,762,387 | -3.1% | 6,977,833 | -4.0% | 0.07% | 0.0% |
Q2 2023 | $733,154,797 | +20.5% | 7,265,431 | +9.8% | 0.07% | +10.8% |
Q1 2023 | $608,530,983 | +3.4% | 6,614,466 | +1.9% | 0.06% | -3.0% |
Q4 2022 | $588,609,281 | +26.7% | 6,488,196 | +6.2% | 0.07% | +6.3% |
Q3 2022 | $464,459,000 | -14.1% | 6,110,503 | -4.5% | 0.06% | -10.0% |
Q2 2022 | $540,890,000 | +88.8% | 6,398,786 | +96.0% | 0.07% | +79.5% |
Q1 2022 | $286,415,000 | -6.0% | 3,263,976 | -6.3% | 0.04% | +2.6% |
Q4 2021 | $304,714,000 | +15.9% | 3,483,649 | +8.3% | 0.04% | +8.6% |
Q3 2021 | $263,003,000 | -2.6% | 3,215,979 | +8.6% | 0.04% | -2.8% |
Q2 2021 | $270,066,000 | +11.2% | 2,959,961 | +4.2% | 0.04% | 0.0% |
Q1 2021 | $242,772,000 | -8.5% | 2,840,099 | +1.1% | 0.04% | -12.2% |
Q4 2020 | $265,253,000 | +19.8% | 2,808,993 | +10.3% | 0.04% | -4.7% |
Q3 2020 | $221,361,000 | -5.7% | 2,545,548 | -5.3% | 0.04% | -17.3% |
Q2 2020 | $234,836,000 | -24.2% | 2,688,755 | -28.4% | 0.05% | -38.1% |
Q1 2020 | $309,675,000 | +17.2% | 3,755,914 | +34.6% | 0.08% | +37.7% |
Q4 2019 | $264,198,000 | +25.0% | 2,790,144 | +14.7% | 0.06% | +8.9% |
Q3 2019 | $211,379,000 | -3.9% | 2,432,441 | +1.0% | 0.06% | -5.1% |
Q2 2019 | $219,999,000 | -25.8% | 2,409,368 | -21.9% | 0.06% | -29.8% |
Q1 2019 | $296,433,000 | +19.7% | 3,083,363 | +6.9% | 0.08% | +13.5% |
Q4 2018 | $247,578,000 | -2.2% | 2,885,187 | -1.8% | 0.07% | +17.5% |
Q3 2018 | $253,191,000 | +15.4% | 2,938,605 | +1.2% | 0.06% | +6.8% |
Q2 2018 | $219,362,000 | -7.2% | 2,903,909 | -0.6% | 0.06% | -10.6% |
Q1 2018 | $236,303,000 | +7.2% | 2,922,721 | +11.3% | 0.07% | +10.0% |
Q4 2017 | $220,455,000 | +10.5% | 2,625,726 | +12.9% | 0.06% | 0.0% |
Q3 2017 | $199,595,000 | +30.7% | 2,324,931 | +27.1% | 0.06% | +30.4% |
Q2 2017 | $152,714,000 | -46.8% | 1,829,567 | -52.7% | 0.05% | +4.5% |
Q1 2017 | $287,260,000 | +9.0% | 3,867,786 | +6.9% | 0.04% | +2.3% |
Q4 2016 | $263,602,000 | +81.8% | 3,618,930 | +97.1% | 0.04% | -14.0% |
Q3 2016 | $145,012,000 | -1.2% | 1,836,516 | +3.3% | 0.05% | -5.7% |
Q2 2016 | $146,745,000 | +12.5% | 1,778,497 | -1.2% | 0.05% | +6.0% |
Q1 2016 | $130,383,000 | -17.0% | 1,799,870 | -1.4% | 0.05% | -12.3% |
Q4 2015 | $157,085,000 | -18.6% | 1,825,725 | -13.1% | 0.06% | -19.7% |
Q3 2015 | $193,010,000 | -12.0% | 2,099,760 | -5.8% | 0.07% | -6.6% |
Q2 2015 | $219,271,000 | +17.1% | 2,229,718 | +17.4% | 0.08% | +10.1% |
Q1 2015 | $187,235,000 | -2.6% | 1,898,730 | -8.5% | 0.07% | -1.4% |
Q4 2014 | $192,222,000 | +10.2% | 2,074,495 | +12.0% | 0.07% | +4.5% |
Q3 2014 | $174,427,000 | +13.2% | 1,853,023 | +8.8% | 0.07% | +11.7% |
Q2 2014 | $154,134,000 | -1.1% | 1,702,578 | -7.1% | 0.06% | -7.7% |
Q1 2014 | $155,886,000 | -10.3% | 1,833,516 | -15.2% | 0.06% | -12.2% |
Q4 2013 | $173,817,000 | +17.7% | 2,162,446 | +12.3% | 0.07% | +5.7% |
Q3 2013 | $147,665,000 | -45.8% | 1,924,978 | -50.0% | 0.07% | -48.9% |
Q2 2013 | $272,459,000 | – | 3,853,208 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |